Table 1 Patient characteristics
From: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
| Characteristic | Number of patients | |
|---|---|---|
| Gender | ||
| male | 14 | |
| female | 4 | |
| Median age, years | 57.9 | |
| Age range, years | 45.1–80.6 | |
| Tumor site | ||
| Larynx | 5 | |
| Oropharynx | 3 | |
| Mouth floor | 2 | |
| Tongue | 2 | |
| Esophagus | 1 | |
| Hypopharynx | 1 | |
| Maxilla | 1 | |
| Nasopharynx | 1 | |
| Sinuses | 1 | |
| Soft palate | 1 | |
| T-Stage | ||
| I | 4 | |
| II | 2 | |
| III | 6 | |
| IV | 6 | |
| N-Stage | ||
| N0 | 4 | |
| N1 | 4 | |
| N2 | 10 | |
| M-Stage | ||
| M0 | 16 | |
| M1 | 2 | |
| Concomitant therapy (in addition to radiotherapy) | ||
| 5-FU + MMC | 12 (patient 3, 5–7, 9–13, 15–17) | |
| MMC | 3 (patient 1, 14, 18) | |
| Cisplatin | 1 (patient 8) | |
| Cetuximab | 1 (patient 4) | |
| none | 1 (patient 2) | |
| Acute Toxicity | ||
| severe | 11 | |
| moderate | 5 | |
| n.a. | 2 | |